What does COVID-19 have to do with the brain?
COVID-19 syndrome includes neurological symptoms in over 30% of patients. This webinar will address molecular approaches from both cellular and organismal viewpoints. How SARS-COV-2 affects the human brain is an important approach to developing diagnostics, and then therapeutic agents, to help patients.
Luiz Eugênio Mello
Scientific Director, FAPESP
University of Campinas (UNICAMP) and FAPESP
Charité Universitaetsmedizin Berlin
University of Campinas (UNICAMP)
Jean Pierre Peron
Institute of Biomedical Sciences, University of São Paulo (ICB/USP)
Marília Zaluar Guimarães
D’Or Institute for Research and Education (IDOR)
and Federal University of Rio de Janeiro (UFRJ)
There will be no certificate/declaration of presence
for events broadcast on YouTube.
You can participate in a Q & A panel. Please, send your comments
and questions (in English or Portuguese) to email@example.com.